Letter to the EditorThere is no reasonable evidence to support efficacy of fluvoxamine in prevention of disease deterioration in COVID-19 outpatients: A comment on two recent meta-analyses advocating its use
Cited by (0)
© 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.